Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
National Institute on Drug Abuse (NIDA)
With
Johns Hopkins University
The pharmacological effects of opioids in opioid dependent individuals can vary as a function of the characteristics of the opioid being studied (e.g., whether it is an agonist, partial agonist, or antagonist; the dose administered; and the route of administration). Another important set of factors influencing the effects produced by opioids is the characteristics of the organism to which the opioid is being administered. One such characteristic is the level of physical dependence in individuals.
Participants in this study will be maintained on different dose levels of an opioid agonist (methadone). The participant will be challenged with a prototypic opioid agonist, antagonist, and a mixed agonist-antagonist with partial agonist features in order to determine the effects that each has on the human body.
Age
18–55
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Active opioid dependence
Qualifies for opioid agonist treatment (e.g., methadone or buprenorphine)
Fulfills DSM-IV diagnostic criteria for opioid dependence
You may not be if
Significant medical problems, including insulin dependent diabetes mellitus
Non-substance use psychiatric disorders (e.g., schizophrenia)